Home > Healthcare Support and Information Services

Healthcare Support and Information Services

 

Molecular testing equipment is in demand at US laboratories

There is still plenty of unmet need in US laboratories for new molecular testing equipment, according to a new Kalorama Information market research report entitled ‘Who's Doing What in Molecular Diagnostics? - The Results of the Kalorama Information/Emmes Group Survey of US Laboratories’.

09 April 2009: Kalorama Information

 

Liquid chromatography market to see steady but slow growth

Kalorama Information predicts that liquid chromatography (LC), an important part of the medical laboratory for years, will see growth from a new application – food safety testing – in the wake of several publicised food scandals.

06 April 2009: Kalorama Information

 

NIBSC merges with Health Protection Agency to extend expert services

The National Institute for Biological Standards and Control (NIBSC) completes merger with the Health Protection Agency.

03 April 2009: Health Protection Agency

 

Health Protection Agency restructures network of environmental health labs

The Health Protection Agency's newly restructured network of regional food, water and environmental laboratories is now operational.

03 April 2009: Health Protection Agency

 

Global dialysis market sees steady growth

Medical market research publisher, Kalorama Information reports in its ‘World Market for Dialysis Equipment and Services’ study that the global dialysis market has experienced five to six percent growth per year in the past five years.

02 April 2009: Kalorama Information

 

New guidance recommends pregnant women should avoid high doses of radiation

New guidance from the Health Protection Agency, The Royal College of Radiologists and the College of Radiographers recommends pregnant women should not undergo some types of medical examination that involve high doses of radiation to the foetus because of the small increased risk of causing childhood cancer.

01 April 2009: Health Protection Agency

 

MEDICAL DEVICE TECHNOL0GY – BUSINESS SUPPORT

FOCUS ZONE REPORT – Tony Davis is the chief executive officer of Medilink West Midlands, an organization that develops business networks for medical and healthcare companies, resulting in commercial ventures and business growth in the West Midlands region of the UK.

31 March 2009: Medilink West Midlands

 

Health Protection Agency releases new HIV statistics

The Health Protection Agency estimates 7,370 new HIV diagnoses were made in the United Kingdom in 2008.

30 March 2009: Health Protection Agency

 

Report predicts global sales of stem cell therapeutics may rise 30 fold by 2013

Market analysts at Kalorama Information estimates there could be a $500 million world market for stem cell therapies by 2013; now that the world’s largest healthcare economy can participate in development.

26 March 2009: Kalorama Information

 

HPA publishes strategy to improve the health of UK children

The Health Protection Agency publishes a strategy to improve the health and well-being of children in the United Kingdom by changing the environment in which they live.

25 March 2009: Health Protection Agency

 

Advanced burn treatments show sales growth spurred on by biologic dressings benefits

Rapid developments in innovative and advanced burn treatments, which include biologic dressings which represent the fastest growing sub-segment, are leading to strong growth, faster recovery times and subsequent cost savings, according to a new report by Kalorama Information ‘Wound Care Markets, 4th Edition, Vol. II: Burns’.

24 March 2009: Kalorama Information

 

NHS hospitals need to improve treatment for children

The Healthcare Commission has published a new report detailing progress by 154 NHS acute trusts since the watchdog reviewed services for children in hospital in 2005/06.

13 March 2009: Healthcare Commission

 

Simbionix collaborates with VirtaMed to support virtual reality hysteroscopy simulator

Simbionix and VirtaMed, a Swiss medical engineering company, have signed a global collaboration agreement that will see Simbionix exclusively distribute, market, and provide service for the VirtaMed HystSim, an advanced virtual reality hysteroscopy simulator.

12 March 2009: Simbionix USA

 

GxP Consulting extends consulting and training services for drug development

GxP Consulting has expanded the company’s range of services as part of its major growth strategy.

09 March 2009: GxP International

 

Skin ulcer treatments help spur growth in global wound care management market

Estimates compiled by Kalorama Information and published in the market analyst’s report entitled ‘Wound Care Markets, 4th Edition, Vol. I: Skin Ulcers’ value the market at $5 billion in 2008 and with annual growth of eight percent through 2013 despite the current recession.

09 March 2009: Kalorama Information

 

Health Protection Agency pinpoints health risk of takeaway kebabs restaurants

Five percent of salads and sauces served in kebab takeaway restaurants in England, Wales and Northern Ireland contain ‘unsatisfactory’ (4.7 percent) and ‘unacceptable’ (0.4 percent) levels of bacteria according to a study carried out by the Health Protection Agency, LACORS (the Local Authorities Co-ordinators of Regulatory Services) and local councils.

06 March 2009: Health Protection Agency

 

Latin America to see growth in demand for ventral hernia repair meshes

Growing demand in Latin America for premium-priced ventral hernia repair meshes, which offer reduced recovery times, lower risk of infection, and lower recurrence rates, will cause revenues in this segment to surpass $20 million by 2013.

02 March 2009: Millennium Research Group

 

DIAGNOSTICS – MARKET FOCUS

FOCUS ZONE REPORT – The Credit Crunch looks unlikely to have a major negative impact on the world in vitro diagnostic test market. The major buffers that will protect the IVD test market will be the worldwide growth in ageing populations around the planet which are increasing demand for healthcare. Emerging markets worldwide are also gaining momentum. Another major boost in the Developed World are the planned federal healthcare initiatives in the USA that look set to provide a new boost to IVD testing.

27 February 2009: Kalorama Information

 

McKesson Health Solutions pilots Uncompensated Care Management scheme

McKesson Health Solutions has launched an Uncompensated Care Management Program which the company is piloting with Baptist Health of Montgomery, Alabama, USA, to decrease the amount of uncompensated care provided within Baptist Health’s hospitals.

26 February 2009: McKesson UK

 

Mortality at 30 days is key therapy attribute for cardiologists for NSTEMI cases

Market analyst, Decision Resources has found that a therapy's effect on incidence of mortality at 30 days is the attribute that most influences surveyed cardiologists' prescribing decisions in non-ST elevation myocardial infarction (NSTEMI).

26 February 2009: Decision Resources

 

MRG report highlights steady growth for drug-eluting stents through to 2013

Millennium Research Group's new market research study entitled ‘US Markets for Interventional Cardiology Devices 2009 report’ indicates that the use of drug-eluting stents will continue to climb steadily through 2013, driven in large part by the adoption of primary percutaneous coronary intervention (PCI) in Acute Myocardial Infarction (AMI) patients, who accounted for nearly 150,000 PCIs in the US in 2008.

19 February 2009: Millennium Research Group

 

Global IVD test market looks set to continue on growth path

Market analysts, Kalorama Information, does not see the global in-vitro diagnostic test market stalling as a result of economic conditions.

06 February 2009: Kalorama Information

 

Market report focuses on interoperability aspects of digital imaging systems

A new report released by market analysts, Kalorama Information shows that the issue of interoperability between digital imaging systems is coming to the forefront.

04 February 2009: Kalorama Information

 

New market report pinpoints the financial impact of HAIs

A new report published by Kalorama Information and entitled ‘Nosocomial Infections: Market Assessment for Diagnostics and Therapeutics’, estimates the financial burden of Hospital acquired infections (HAI) is between $4.5 billion and $5.78 billion annually.

03 February 2009: Kalorama Information

 

New biological search portal for exploring dynamic gene-based content goes live

Sigma-Aldrich and Ingenuity Systems have launched Your Favorite Gene powered by Ingenuity, a web-based biological search portal for exploring dynamic gene-based content (http://www.sigma-aldrich.com/yfg).

28 January 2009: Sigma-Aldrich Research Biotech

 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
 

 

 

© 2010 ProHealthServiceZone.com